Latest NextCell Pharma News & Updates
See the latest news and media coverage for NextCell Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish stem cell biotechnology company
nextcellpharma.com- Headquarters
- Huddinge, Sweden
- Founded year
- 2014
- Company type
- Public company
- Number of employees
- 15–50
Last updated
Latest news about NextCell Pharma
In short: NextCell Pharma launched a commercial platform with FUJIFILM and reported long-term clinical success for its ProTrans diabetes therapy.
Company announcements
-
NextCell and FUJIFILM Biosciences launch NextCell-Cord RUO
The product is a standardized MSC solution for research, available globally via FUJIFILM. It combines NextCell's cells with optimized culture medium.
-
NextCell Pharma publishes annual report 2024/2025
The annual report for the fiscal year 1 September 2024–31 December 2025 is available as an attachment or on the company's website. The share is traded on Nasdaq First North Growth Market under the short name NXTCL.
-
NextCell Pharma calls for annual general meeting
The meeting is held on May 27, 2026 in Huddinge with proposals on board election, incentive program and changes to the articles of association.
-
NextCell announces ProTrans phase II study accepted in Cytotherapy
The study evaluated safety and efficacy of ProTrans in covid-19 complications. It confirms short-term safety and the platform's robustness.
Media coverage
-
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media
Collaboration results in platform to help researchers overcome challenges in MSC research...
-
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media
FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company specializing in cell therapy using umbilical cord mesenchymal...
-
NextCell Pharma (year-end report review): Making progress | MarketScreener
Redeye’s analyst just published a Research Update on NextCell Pharma.Click here to read the articleMake sure to add NextCell Pharma to your Watchlist at Redeye...
-
NextCell Pharma AB: Seven-year follow-up data from ProTrans-Repeat demonstrate sustained disease-modifying effects of ProTrans in type 1 diabetes
NextCell Pharma AB ("NextCell" or the "Company") today announces long-term follow-up data from the ProTrans-Repeat study showing sustained preservation of endogenous insulin production in patients...
Track NextCell Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
NextCell Pharma competitors & trending companies
Browse news for competitors to NextCell Pharma and other trending companies.
Diamyd Medical
BioCrine
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze